Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Price to Cash Earnings (PCE)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   PCE(x) 6.537.707.08-6.31-

What is the latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) ?

The latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) is 6.53 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20256.53
Mar20247.70
Mar20237.08
Mar2022-6.31
Mar2013-

How is Price to Cash Earnings (PCE) of NATH BIOGENES (INDIA) Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 6.53
-15.19
Mar2024 7.7
8.76
Mar2023 7.08
Positive
Mar2022 -6.31
0
Mar2013 0 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Price to Cash Earnings (PCE) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹299.3 Cr 4.3% 4.6% -16.1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,797.2 Cr -3.7% -0.5% -12.5% Stock Analytics
KAVERI SEED COMPANY ₹5,034.1 Cr 5.1% 0.7% 12.9% Stock Analytics
VENKYS (INDIA) ₹2,090.8 Cr 5.6% 10.7% -17.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,160.4 Cr 10% 0.3% -23.4% Stock Analytics
INDO US BIOTECH ₹245.7 Cr -0.5% -7.4% -63.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

4.3%

4.6%

-16.1%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses